Epidemiologic features of the presentation of critical congenital heart disease: Implications for screening

Pediatrics

Volumn 121, Issue 4, 2008, Pages 751-757

  Schultz, Amy H ^a,c   Localio, A Russell ^a   Clark, Bernard J ^a   Ravishankar, Chitra ^a   Videon, Nancy ^b   Kimmel, Stephen E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular anomalies; Epidemiology; Screening

Indexed keywords

AORTA ARCH; AORTA OCCLUSION; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HEART ARREST; HUMAN; INCIDENCE; KIDNEY INJURY; LABORATORY DIAGNOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; NEWBORN; NEWBORN SCREENING; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; CAUSE OF DEATH; CONGENITAL HEART MALFORMATION; HOSPITAL; METHODOLOGY; MORTALITY; RISK ASSESSMENT; SURVIVAL; UNITED STATES;

CAUSE OF DEATH; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HEART DEFECTS, CONGENITAL; HOSPITAL MORTALITY; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PENNSYLVANIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 42949095538     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-0421     Document Type: Article

References (25)

1. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation. 2001;103(19):2376-2381
2. National Perinatal Statistics. March of Dimes Perinatal Data Center; 2002. Available at: www.marchofdimes.com/professionals/680 - 1239.asp. Accessed February 20, 2008
3. Live Births by Race of Mother, Infant Deaths, and Infant Mortality Rates by Race of Mother and 130 Selected Causes of Death, United States, 2000. National Center for Health Statistics. Available at: www.cdc.gov/nchs/datawh/ statab/unpubd/ mortabs.htm. Accessed September 29, 2003
4. Marino BS, Bird G, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol. 2001;28(1):91-136
5. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child. 1994;71(1):3-7
6. Heymann MA, Rudolph AM. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia. Pediatrics. 1977;59(3):325-329
7. Newborn Screening: Characteristics of State Programs. Washington, DC: US General Accounting Office; 2003. GAO-03-449
8. US National Screening Status Report. National Newborn Screening and Genetics Resource Center; 2008. Available at: http://genes-r- us.uthscsa.edu/nbdisorders.pdf. Accessed February 20, 2008
9. Keren R, Helfand M, Homer C, McPhillips H, Lieu TA. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics. 2002;110(5):855-864
10. Clancy RR, McGaurn SA, Wernovsky G, et al. Preoperative risk-of-death prediction model in heart surgery with deep hy- pothermic circulatory arrest in the neonate. J Thorac Cardiovasc Surg. 2000;119(2):347-357
11. Report of the New England Regional Infant Cardiac Program. Pediatrics. 1980;65(2 pt 2):375-461
12. Mellander M, Sunnegardh J. Failure to diagnose critical heart malformations in newborns before discharge: an increasing problem? Acta Paediatr. 2006;95(4):407-413
13. Crossland DS, Furness JC, Abu-Harb M, Sadagopan SN, Wren C. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F325-F327
14. Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2005;9(44):1-152
15. Hoke TR, Donohue PK, Bawa PK, et al. Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatr Cardiol. 2002;23(4):403-409
16. Koppel RI, Druschel CM, Carter T, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics. 2003;111(3):451-455
17. Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003;142(3):268 -272
18. Richmond S, Reay G, Abu HM. Routine pulse oximetry in the asymptomatic newborn. Arch Dis Child Fetal Neonatal Ed. 2002; 87(2):F83-F88
19. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26(6):832-835
20. Arlettaz R, Bauschatz AS, Monkhoff M, Essers B, Bauersfeld U. The contribution of pulse oximetry to the early detection of congenital heart disease in the newborn. Eur J Pediatr. 2006; 165(2):94-98
21. Rosati E, Chitano G, Dipaola L, De Felice C, Latini G. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med. 2005;33(5):455-457
22. de Wahl Granelli A, Mellander M, Sunnegardh J, Sandberg K, Ostman-Smith I. Screening for duct-dependent congenital heart disease with pulse oximetry: a critical evaluation of strategies to maximize sensitivity. Acta Paediatr. 2005;94(11):1590 -1596
23. Liske MR, Greeley CS, Law DJ, et al. Report of the Tennessee task force on screening newborn infants for critical congenital heart disease. Pediatrics. 2006;118(4). Available at: www.pediatrics.org/cgi/content/ full/118/4/e1250
24. Sharland GK, Allan LD. Screening for congenital heart disease prenatally: results of a 2 1/2 year study in the south east Thames region. Br J Obstet Gynaecol. 1992;99(3):220-225
25. Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonogra- phers. Heart. 2000;84(3):294-298